April 12, 2021 | Leadership
Matthew Gantz is President and Chief Executive Officer of Castle Creek Biosciences, Inc., and a member of the company’s Board of Directors. An accomplished life sciences executive with more than 25 years of experience in the specialty biopharmaceutical and medical device industries, Mr. Gantz previously served as Chief Executive Officer of OxThera AB. Prior to […]
Read MoreFebruary 21, 2025 | CCB People| Leadership
David Chu is the Chief Medical Officer of Castle Creek Biosciences, Inc. Dr. Chu has over 20 years of experience in dermatology, academic research, clinical practice, and pharmaceutical development. He previously served as Vice President, Clinical Development, at Arcutis Biotherapeutics, where he led clinical programs that supported the approval of multiple indications for Zoryve, a topical […]
Read MoreFebruary 08, 2023 | Leadership
Christopher Ballas is Chief Technology Officer at Castle Creek Biosciences, Inc. He has over 25 years of experience with cell and gene therapies in academic and industry roles covering research, development, testing, and manufacturing of viral vectors and cell therapies. Dr. Ballas recently was the Sr. Vice President of Manufacturing for Innovative Cellular Therapeutics. Prior […]
Read MoreJune 30, 2022 | Leadership
Matt Crabtree is the Vice President of Finance at Castle Creek Biosciences, Inc. He is responsible for financial accounting and reporting, budgeting, treasury management, tax, and information technology. Mr. Crabtree began his career at KPMG and has nearly 20 years of financial expertise. Previously he was a Senior Vice President, Corporate Controller for Customers […]
Read MoreJuly 05, 2020 | Leadership
Robin Blumenthal is the Associate Vice President of Clinical Operations at Castle Creek Biosciences, Inc. Previously she held key clinical operations positions at Menlo Therapeutics, Pfizer and Anacor. Her extensive background in immunology and clinical operations has consistently contributed to the successful development and management of complex clinical programs. Dr. Blumenthal holds a Ph.D. in […]
Read MoreMarch 30, 2023 | Leadership
Savita Mehra is Vice President of Quality Assurance at Castle Creek Biosciences, Inc. She has over 30 years of experience in developing, implementing, and successfully sustaining quality management systems in various manufacturing sectors, including gene therapy and biologics, and assuring compliance to regulatory requirements. Ms. Mehra has been a liaison for the FDA, EU and […]
Read More